The diagnosis of diabetes is made with any of the following criteria:
FPG ≥7.0 mmol/L
A1C ≥6.5% (in adults, in the absence of factors affecting A1C accuracy; not for those with suspected type 1 diabetes)
2hPG in a 75 g OGTT ≥11.1 mmol/L
Random plasma glucose (PG) ≥11.1 mmol/L
Measure levels of B-type natriuretic peptide (BNP)/N-terminal pro BNP (NT-proBNP) to help confirm/exclude a diagnosis of heart failure in an acute/ambulatory care setting when the cause of dyspnea is in doubt.
Before initiating cancer therapy known to impair left ventricular (LV) function in patients receiving potentially cardiotoxic cancer treatment, evaluate their LV ejection fraction (LVEF).
Laboratory workup includes the following tests:
Blood chemisty (potassium, sodium, creatinine)
FBG and/or A1C
Serum total cholesterol, LDL, HDL, non-HDL-C, TGs; lipids may be drawn fasting/nonfasting
Standard 12-lead electrocardiography
Obtain echocardiography or nuclear imaging to assess LVEF in hypertensive patients with heart failure.
Consider regular home BP monitoring for hypertensive patients, particularly those with diabetes mellitus, chronic kidney disease, suspected nonadherence, demonstrated white coat effect, or masked hypertension (BP controlled in the office but not at home).
In patients whose large arm circumferences preclude use of standard upper arm measurement methods, use validated wrist devices for assessing BP.
When appropriate, obtain additional investigations (eg, liver enzyme tests, sleep studies) to screen for and exclude other common overweight/obesity-related health issues.
Medscape © 2018 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Cardiovascular Disease Prevention and Management Clinical Practice Guidelines (2018) - Medscape - Nov 01, 2018.